Cargando…

Patient and Provider Reported Reasons for Lost to Follow Up in MDRTB Treatment: A Qualitative Study from a Drug Resistant TB Centre in India

INTRODUCTION: Multidrug-resistant Tuberculosis (MDR TB) is emerging public health concern globally. Lost to follow-up (LTFU) is one of the key challenge in MDRTB treatment. In 2013, 18% of MDR TB patients were reported LTFU in India. A qualitative study was conducted to obtain better understanding o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deshmukh, Rajesh D., Dhande, D. J., Sachdeva, Kuldeep Singh, Sreenivas, Achuthan, Kumar, A. M. V., Satyanarayana, Srinath, Parmar, Malik, Moonan, Patrick K., Lo, Terrence Q.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4547708/ https://www.ncbi.nlm.nih.gov/pubmed/26301748 http://dx.doi.org/10.1371/journal.pone.0135802

Ejemplares similares

Source of Previous Treatment for Re-Treatment TB Cases Registered under the National TB Control Programme, India, 2010
por: Sachdeva, Kuldeep Singh, et al.
Publicado: (2011)

Tackling challenges of TB/MDRTB in China: concerted actions are imperative
por: Tang, Shenglan
Publicado: (2015)

Operational Challenges in Diagnosing Multi-Drug Resistant TB and Initiating Treatment in Andhra Pradesh, India
por: Chadha, Sarabjit S., et al.
Publicado: (2011)

Evaluation of TB Case Finding through Systematic Contact Investigation, Chhattisgarh, India
por: Khaparde, Kshitij, et al.
Publicado: (2015)

How Did the TB Patients Reach DOTS Services in Delhi? A Study of Patient Treatment Seeking Behavior
por: Kapoor, Sunil K., et al.
Publicado: (2012)

Unacceptable treatment outcomes and associated factors among India's initial cohorts of multidrug-resistant tuberculosis (MDR-TB) patients under the revised national TB control programme (2007–2011): Evidence leading to policy enhancement
por: Parmar, Malik M., et al.
Publicado: (2018)

Catching the Missing Million: Experiences in Enhancing TB & DR-TB Detection by Providing Upfront Xpert MTB/RIF Testing for People Living with HIV in India
por: Raizada, Neeraj, et al.
Publicado: (2015)

Enhancing TB Case Detection: Experience in Offering Upfront Xpert MTB/RIF Testing to Pediatric Presumptive TB and DR TB Cases for Early Rapid Diagnosis of Drug Sensitive and Drug Resistant TB
por: Raizada, Neeraj, et al.
Publicado: (2014)

What Are the Reasons for Poor Uptake of HIV Testing among Patients with TB in an Eastern India District?
por: Bishnu, Bipra, et al.
Publicado: (2013)

Piloting Upfront Xpert MTB/RIF Testing on Various Specimens under Programmatic Conditions for Diagnosis of TB & DR-TB in Paediatric Population
por: Raizada, Neeraj, et al.
Publicado: (2015)

What can we offer to 3 million MDRTB household contacts in 2016?
por: Moore, David A. J.
Publicado: (2016)

Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India
por: Sachdeva, Kuldeep Singh, et al.
Publicado: (2015)

Impact of Introducing the Line Probe Assay on Time to Treatment Initiation of MDR-TB in Delhi, India
por: Singla, Neeta, et al.
Publicado: (2014)

Is One Sputum Specimen as Good as Two during Follow-Up Cultures for Monitoring Multi Drug Resistant Tuberculosis Patients in India?
por: Nagaraja, Sharath Burugina, et al.
Publicado: (2012)

New Vision for Revised National Tuberculosis Control Programme (RNTCP): Universal access - “Reaching the un-reached”
por: Sachdeva, Kuldeep Singh, et al.
Publicado: (2012)

How Do Patients Who Fail First-Line TB Treatment but Who Are Not Placed on an MDR-TB Regimen Fare in South India?
por: Burugina Nagaraja, Sharath, et al.
Publicado: (2011)

Use of Verbal Autopsy to Determine Underlying Cause of Death during Treatment of Multidrug-Resistant Tuberculosis, India
por: Naik, Poonam Ramesh, et al.
Publicado: (2018)

Addressing diabetes mellitus as part of the strategy for ending TB
por: Harries, Anthony D., et al.
Publicado: (2016)

Developing a model to predict unfavourable treatment outcomes in patients with tuberculosis and human immunodeficiency virus co-infection in Delhi, India
por: Madan, Chandravali, et al.
Publicado: (2018)

A model to determine effective HIV/AIDS and Multi-Drug Tuberculosis (MDRTB) treatment policies: a case study from the Russian Federation
por: Lebcir, Reda
Publicado: (2010)

Scaling Up TB Screening and TB Preventive Treatment Globally: Key Actions and Healthcare Service Costs
por: Satyanarayana, Srinath, et al.
Publicado: (2023)

Unusual Interferon Gamma Measurements with QuantiFERON-TB Gold and QuantiFERON-TB Gold In-Tube Tests
por: Powell, Richard D., et al.
Publicado: (2011)

Multicenter Noninferiority Evaluation of Hain GenoType MTBDRplus Version 2 and Nipro NTM+MDRTB Line Probe Assays for Detection of Rifampin and Isoniazid Resistance
por: Nathavitharana, Ruvandhi R., et al.
Publicado: (2016)

Active Case Finding for Tuberculosis in India: A Syntheses of Activities and Outcomes Reported by the National Tuberculosis Elimination Programme
por: Burugina Nagaraja, Sharath, et al.
Publicado: (2021)

Addressing poverty through disease control programmes: examples from Tuberculosis control in India
por: Kamineni, Vishnu Vardhan, et al.
Publicado: (2012)

Comparative Evaluation of GenoType MTBDRplus Line Probe Assay with Solid Culture Method in Early Diagnosis of Multidrug Resistant Tuberculosis (MDR-TB) at a Tertiary Care Centre in India
por: Yadav, Raj N., et al.
Publicado: (2013)

Correction: Comparative Evaluation of GenoType MTBDRplus Line Probe Assay with Solid Culture Method in Early Diagnosis of Multidrug Resistant Tuberculosis (MDR-TB) at a Tertiary Care Centre in India
por: Yadav, Raj N., et al.
Publicado: (2013)

Factors Associated with Tuberculosis and Rifampicin-Resistant Tuberculosis amongst Symptomatic Patients in India: A Retrospective Analysis
por: Nair, Sreenivas Achuthan, et al.
Publicado: (2016)

Scaling-up the Xpert MTB/RIF assay for the detection of tuberculosis and rifampicin resistance in India: An economic analysis
por: Khaparde, Sunil, et al.
Publicado: (2017)

Patients Lost to Follow-up in Shoulder Arthroplasty: Descriptive Characteristics and Reasons
por: Torrens, Carlos, et al.
Publicado: (2022)

Sputum Smear Microscopy at Two Months into Continuation-Phase: Should It Be Done in All Patients with Sputum Smear-Positive Tuberculosis?
por: Gandhi, Mohit Padamchand, et al.
Publicado: (2012)

Comparing Same Day Sputum Microscopy with Conventional Sputum Microscopy for the Diagnosis of Tuberculosis – Chhattisgarh, India
por: Nayak, Priyakanta, et al.
Publicado: (2013)

Draft Genome Sequence of Multidrug-Resistant Mycobacterium tuberculosis Strain CWCFVRF MDRTB 670, Isolated from the Sputum of a Patient from Chennai, India, with Clinically Suspected Tuberculosis
por: Lakshmipathy, Dhanurekha, et al.
Publicado: (2014)

An Opportunity to END TB: Using the Sustainable Development Goals for Action on Socio-Economic Determinants of TB in High Burden Countries in WHO South-East Asia and the Western Pacific Regions
por: Satyanarayana, Srinath, et al.
Publicado: (2020)

Characteristics and Programme-Defined Treatment Outcomes among Childhood Tuberculosis (TB) Patients under the National TB Programme in Delhi
por: Satyanarayana, Srinath, et al.
Publicado: (2010)

Building communities of practice through case-based e-learning to prevent and manage TB among people living with HIV–India
por: Agarwal, Reshu, et al.
Publicado: (2022)

Predictors and Timing of ATT Initiation among HIV-TB Patients at ART Centers of Karnataka, India: Two Year Follow-Up
por: Shastri, Suresh, et al.
Publicado: (2015)

Linkage of Presumptive Multidrug Resistant Tuberculosis (MDR-TB) Patients to Diagnostic and Treatment Services in Cambodia
por: Khann, Sokhan, et al.
Publicado: (2013)

Intensified Tuberculosis Case Finding among Malnourished Children in Nutritional Rehabilitation Centres of Karnataka, India: Missed Opportunities
por: Bhat, Prashant G., et al.
Publicado: (2013)

The Potential Impact of Up-Front Drug Sensitivity Testing on India’s Epidemic of Multi-Drug Resistant Tuberculosis
por: Sachdeva, Kuldeep Singh, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_s97e7e9kgus01h29d3orrcrlil